Grants for For profit organizations other than small businesses - Health

This funding opportunity supports the development of a national data resource center to improve research on childhood cancers and congenital anomalies, encouraging collaboration among a wide range of organizations and researchers.

This funding opportunity provides financial support for research projects that investigate the factors influencing research integrity and misconduct in biomedical and behavioral sciences, aimed at improving the reliability and credibility of federally funded research.

This funding opportunity is designed for organizations with extensive experience in criminal justice research to evaluate and improve the decision-making processes used by state Departments of Corrections for placing individuals in community reentry facilities.

This program provides funding to a wide range of organizations, including nonprofits, universities, and businesses, to develop innovative solutions for producing personalized genetic medicines quickly and efficiently, improving patient access across the United States.

This funding opportunity provides $5 million annually to organizations that will enhance mental health care access across New York State by equipping non-psychiatric healthcare providers with the necessary tools and support to effectively assess and treat mental health conditions, particularly for underserved populations.

This funding opportunity is designed to establish a center that will coordinate and manage data for collaborative research on rare diseases, supporting various research consortia and engaging stakeholders to improve diagnosis and treatment.

This ISO seeks solution summaries and proposals for projects that fall within the general scope of the ARPA-H Scalable Solutions mission office. SSO expands what is technically possible by developing approaches that will leverage an interdisciplinary approach and collaborative networks to address challenges of geography, distribution, manufacturing, data and information, thereby improving health care access and affordability. In the United States, many communities and remote areas lack access to timely and quality health care, which leads to disparities in health outcomes for those populations. Bottlenecks during the manufacturing processes of products and health technologies also lead to delays and limited availability, preventing effective distribution of health care solutions to areas of need, especially in emergencies.ARPA-H SSO seeks solutions to improve the scalability and affordability of health care solutions, bridge gaps in underserved areas, and extend remote access to expertise by developing location-specific interventions, telemedicine solutions, and mobile health clinics. Solutions should focus on rapid innovation and the use of partnerships, as well as flexible distribution networks and streamlined manufacturing processes. The following SSO interest areas categorize the ground-breaking solutions we seek to support:Scalable Technologies and Interventions: Approaches to improve affordability and equitable access to health care that are adaptable to various geographic, demographic, economic contexts and can be rapidly deployed at scale (e.g., drug-repurposing*, telemedicine, point-of-care diagnostics, and modular health care infrastructure). Tailored solutions for the pediatric population that provide parity in access to treatments and other health care interventions with the adult population and adapt to the pediatric patients changing physiology and developmental status over the course of years. Transformational approaches to reduce or eliminate health disparities, including tools and models for product design and care delivery that scale novel approaches in human factors and human-centered design to respond to full diversity of patients. Tools to enable the scaling of provider and institutional capabilities (e.g., school nurses and schools, walk-in clinics, homesteading care) to address unmet health care access needs and expand availability of critical services. Foundational capabilities to accelerate diagnoses and reduce the cost of treatments for rare diseases wherever patients are, without the need for specialized facilities or healthcare expertise.* Solution summaries and proposals that focus on testing drugs for effectiveness for other disease states or use cases, are unlikely to be funded unless including additional R, or providing gains in cost reduction, accessibility, and/or equity.Collaborative Distribution Networks: Methods for standardization, automation, and democratization of complex procedures 5 including, but not limited to, histopathology, rare disease diagnosis and treatment, and surgical interventions to ensure access and delivery to populations diverse in demographics, geographies, and resources at scale. Approaches to enhance delivery of effective healthcare solutions in rural or low resource settings, including but not limited to "last mile delivery, at-home monitoring, imaging, drug delivery, telehealth augmentation, and support for remote medical procedures with limited need for specialized training. Technologies to enable the deployment of critical healthcare resources rapidly, equitably, and securely at scale to the point of need in permissive and non-permissive (i.e., damaged infrastructure, cyber-denied) environments during a public health crisis or natural disaster. Solutions to scale education and training of critical healthcare resources for health care providers and patients to ensure information integrity to prevent negative impacts to resource use/uptake. Innovative information technology, data and analytic products and technologies to enable ordering, inventory management, situational awareness, allocation planning and demand forecasting of critical healthcare resources during a public health crisis or natural disaster.Biomanufacturing Innovations*: Innovative manufacturing technologies and approaches that reduce cost, shorten the timeline for production, advance domestic competitiveness and reduce supply chain risk of biologics, cellular and gene therapies, pharmaceuticals, medical devices and personal protective equipment. New approaches to support predictable, programable biological production of conventional and novel materials reliability at scale in a cost-effective sustainable manner. Novel solutions to reduce the reliance on specialized handling and cold chain management of pharmaceuticals and biologics. Scalable innovations to advance and strengthen biomanufacturing supply chain and resolve bottlenecks including:o Advances in production of active pharmaceutical ingredients, process consumables, and other critical materials (i.e., enzymes, cell lines, etc);o Novel biomanufacturing-related data products, technologies or models to integrate into supply chain situational awareness systems;o Alternative materials and new manufacturing capabilities for personal protective equipment; ando Improvement of capabilities sustainably re-shore manufacturing and utilize a broad array of readily accessible and cost-efficient feedstocks as part of strengthening the local and national industry base. Analytics and novel sensor systems to precisely manage bioproduction, real-time release assays, and predictive capabilities to inform tuning of biological chassis for efficient and effective scale-up of manufacturing to industrial scale.*ARPA-H is not interested in approaches that merely increase capacity reservation.Other high-quality submissions that propose revolutionary technologies that meet the goals of SSO will be considered even if they do not address the topics listed above.Proposals are expected to use innovative approaches to enable revolutionary advances in medicine and healthcare, and the science and technology underlying these areas. While approaches that are disease agnostic are encouraged, ARPA-H welcomes proposals that bring radically new insights to address specific diseases including, but not limited to, cancer, diabetes, neurological diseases, pediatric and maternal/fetal health, infectious diseases, and cardiovascular disease.Specifically excluded are proposals that represent an evolutionary or incremental advance in the current state of the art or technology that has reached the clinical trial stage. An example of this type of proposal might include the request to fund clinical trials of an otherwise developed product. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission.

This funding opportunity supports cities, counties, and organizations in Iowa to implement urban conservation projects that reduce nutrient pollution and improve water quality through stormwater management and community education.

The purpose of this NIDCD initiative is to encourage research in the development, characterization, and reproducibility/reliability of human auditory and vestibular organoids.Applications investigating animal organoids are allowable but only if accompanying comparative or other integrated companion studies with human organoids. Singular animal organoid studies alone are not responsive to this funding opportunity. This funding opportunity encourages innovative, reproducible, and novel methodologies and technologies that will drive the reproducibility and holistic longevity of hearing/balance sensory organoids as model systems. The development of novel tools to deliver genes, proteins, molecules, and synthetics that might lead to the successful expansion and longer-term survivability of organoid populations in a stable, reliable, and reproducible manner is highly encouraged. Subsequent characterization of the organoid platforms must be shown to mimic and recapitulate the native correlative biological function. Applications that provide approaches that remove current barriers and lessen challenges to improve current reproducibility and stability are highly encouraged. Applications that have breakthrough approaches and technologies using human auditory/vestibular organoids are highly encouraged.

This funding opportunity provides financial support for community-driven projects in Butte County that aim to improve air quality and reduce exposure to harmful pollutants, particularly in disadvantaged neighborhoods.

This funding opportunity provides financial support to organizations that develop training programs for healthcare providers and emergency responders to improve the management of maternal health emergencies in low-resource settings across the United States.

The OneOhio Recovery Foundation’s first round of grants will be awarded to eligible organizations that apply and are selected for funding by one of the 19 OneOhio Regions. To be considered for funding, applicants must demonstrate the program or services intended for funding align with the Approved Purposes and the Ohio Abatement Strategies detailed in the OneOhio Memorandum of Understanding (MOU).

This funding opportunity supports projects that promote responsible research practices and integrity by providing financial assistance to a wide range of organizations, including educational institutions and nonprofits, to develop innovative tools and training programs.

All work supported under this Grant will focus on reducing health disparities for the populations across the state impacted by the high prevalence of cardiovascular (CVD), exacerbated by health inequities and disparities, social determinants, such as low incomes, poor health care, and unfair opportunity structures.  Financial Notes: Funds for the Umbrella Hub Arrangement come from the Centers for Disease Control and Prevention (CDC), A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes CDC-RFA-DP-23-0020 grant (230020).

The City of Boulder Health Equity Fund (HEF) Request for Proposals (RFP) is designed to support community-based health equity programs for Boulder residents experiencing health disparities. The fund aims to reduce systemic socio-economic and health barriers, aligning with the city's mission to achieve health equity—defined as the absence of systematic health disparities and the ability of all residents to reach their full health potential regardless of life circumstances. This initiative directly supports health and wellness programs that address these disparities. The target beneficiaries of the HEF include residents disproportionately impacted by diseases linked to sugar-sweetened beverage consumption or targeted by SSB marketing, those lacking access to healthy food, safe water, quality health care, wellness information, and health care services, and populations systemically disenfranchised due to race, ethnicity, income, age, ability, sexual orientation, or gender identification. The primary impact goal is to improve health equity and reduce health disparities within these vulnerable communities. The HEF prioritizes programs that benefit individuals most affected by or at increased risk from chronic diseases linked to sugary drink consumption, or who generally experience health disparities. Key focuses include health services for prevention of obesity, diabetes, heart disease, and oral diseases, increased access to healthy food and clean water, wellness programs, and physical fitness. The program also emphasizes leadership diversity reflective of client demographics, alignment with program priorities, evidence-based practices, and valuing lived experience and cultural knowledge. Expected outcomes and measurable results include long-term evaluation of outcomes, meaningful engagement of community members in program design and implementation, strong collaborations, cost-effectiveness, and demonstrated financial stability and diverse funding sources for applying agencies. The City of Boulder's strategic priority is to fund programs that directly address health inequities and contribute to a community where all residents can achieve their full health potential. The underlying theory of change is that by investing in targeted, community-based health and wellness programs, the city can systematically dismantle health barriers and create a more equitable health landscape for its residents.

This funding opportunity supports the development of integrated healthcare networks among rural healthcare providers in the Delta region to improve access, quality, and efficiency of care for underserved communities.

This funding opportunity provides support to organizations that assist state and local correctional facilities in implementing effective substance use treatment and aftercare programs for incarcerated individuals.

This funding opportunity is designed to help mental health providers establish or expand intensive outpatient programs for children and adolescents in New York State, particularly in underserved areas, to improve access to essential mental health services.

This funding opportunity provides financial support to a variety of organizations, including health systems and community groups, to implement and evaluate innovative lifestyle medicine interventions aimed at improving health outcomes and reducing costs for Medicare beneficiaries.

This funding opportunity provides financial support to organizations that assist healthcare providers in expanding telehealth services, particularly in rural and underserved areas across the United States.